These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 570744)

  • 1. Formation and properties of a thrombin generated factor IX inhibitor.
    Marlar RA; Seegers WH
    Thromb Res; 1979 Jan; 14(1):95-105. PubMed ID: 570744
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and characterization of bovine factor IX (Christmas factor).
    Fujikawa K; Thompson AR; Legaz ME; Meyer RG; Davie EW
    Biochemistry; 1973 Nov; 12(24):4938-45. PubMed ID: 4796921
    [No Abstract]   [Full Text] [Related]  

  • 3. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.
    Osterud B; Bouma BN; Griffin JH
    J Biol Chem; 1978 Sep; 253(17):5946-51. PubMed ID: 681330
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation.
    Jackson CM; Nemerson Y
    Annu Rev Biochem; 1980; 49():765-811. PubMed ID: 6996572
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of factor IX by activated factor X: a link between the extrinsic and intrinsic coagulation systems.
    Kalousek F; Konigsberg W; Nemerson Y
    FEBS Lett; 1975 Feb; 50(3):382-5. PubMed ID: 1116608
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation: a cybernetic system.
    Seegers WH
    Ser Haematol; 1973; 6(4):549-78. PubMed ID: 4277382
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).
    Fujikawa K; Legaz ME; Kato H; Davie EW
    Biochemistry; 1974 Oct; 13(22):4508-16. PubMed ID: 4473201
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms in blood coagulation.
    Davie EW; Kirby EP
    Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
    [No Abstract]   [Full Text] [Related]  

  • 10. Human factor IX and factor IXa.
    Bajaj SP; Birktoft JJ
    Methods Enzymol; 1993; 222():96-128. PubMed ID: 8412817
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor.
    Zur M; Nemerson Y
    J Biol Chem; 1980 Jun; 255(12):5703-7. PubMed ID: 7380833
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of factor IX by thrombin preparations in the absence of factor XI.
    Irwin JF; Mammen EF
    Thromb Res; 1976 Feb; 8(2):141-9. PubMed ID: 814650
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired factor IX-inhibitor in a non-hemophilic patient with autoimmune disease].
    Largo R; Sigg P; von Felten A; Straub PW
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1612-3. PubMed ID: 4645050
    [No Abstract]   [Full Text] [Related]  

  • 18. Small synthetic peptides with affinity for proteases in coagulation and fibrinolysis: an overview.
    Claeson G; Aurell L
    Ann N Y Acad Sci; 1981; 370():798-811. PubMed ID: 6455958
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and some characteristics of the coagulation factor IX from human plasma.
    Osterud B; Flengsrud R
    Biochem J; 1975 Mar; 145(3):469-74. PubMed ID: 1171684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
    Osterud B; Rapaport SI
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5260-4. PubMed ID: 271951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.